Klaria Pharma posts Q2 2026 interim report for April-June period

Reuters2026/08/31 22:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Klaria Pharma published a corrected Q2 2026 interim report for April 1–June 30, 2026.
Q2 net loss totaled SEK 12.9 million. Cash and cash equivalents were SEK 8.5 million at June 30.
The report was posted at https://attachment.news.eu.nasdaq.com/a54d6a61b7fa970560bf5dd992aa3111d.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Klaria Pharma posts Q2 2026 interim report for April-June period

You may also like

Crypto prices